Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galapagos (GLPG –
Tag: Brian Abrahams
NeuBase Therapeutics (NBSE) Receives a Buy from RBC Capital
RBC Capital analyst Brian Abrahams maintained a Buy rating on NeuBase Therapeutics (NBSE – Research Report) on February 11 and
RBC Capital Keeps a Hold Rating on Theratechnologies (THTX)
In a report issued on January 7, Brian Abrahams from RBC Capital maintained a Hold rating on Theratechnologies (THTX –
RBC Capital Reaffirms Their Hold Rating on Intercept Pharma (ICPT)
In a report issued on January 7, Brian Abrahams from RBC Capital maintained a Hold rating on Intercept Pharma (ICPT
RBC Capital Reaffirms Their Hold Rating on Enanta Pharmaceuticals (ENTA)
In a report issued on January 7, Brian Abrahams from RBC Capital maintained a Hold rating on Enanta Pharmaceuticals (ENTA
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (NASDAQ: VRTX) and Global Blood Therapeutics (NASDAQ: GBT)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals
Analysts Offer Insights on Healthcare Companies: Galapagos (NASDAQ: GLPG) and Mesoblast (NASDAQ: MESO)
Analysts fell to the sidelines weighing in on Galapagos (GLPG – Research Report) and Mesoblast (MESO – Research Report) with